Canada Life’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Canada Life’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-22,700	Closed	-$38K	–	2803
2018 Q3	$38K	Hold	22,700	–	–	﹤0.01%	2442
2018 Q2	$39K	Hold	22,700	–	–	﹤0.01%	2454
2018 Q1	$41K	Hold	22,700	–	–	﹤0.01%	2410
2017 Q4	$51K	Hold	22,700	–	–	﹤0.01%	2362
2017 Q3	$59K	Hold	22,700	–	–	﹤0.01%	2303
2017 Q2	$101K	Hold	22,700	–	–	﹤0.01%	2121
2017 Q1	$105K	Hold	22,700	–	–	﹤0.01%	2103
2016 Q4	$139K	Hold	22,700	–	–	﹤0.01%	2013
2016 Q3	$125K	Hold	22,700	–	–	﹤0.01%	2059
2016 Q2	$86K	Hold	22,700	–	–	﹤0.01%	2161
2016 Q1	$62K	Hold	22,700	–	–	﹤0.01%	2042
2015 Q4	$129K	Hold	22,700	–	–	﹤0.01%	1579
2015 Q3	$120K	Hold	22,700	–	–	﹤0.01%	1582
2015 Q2	$188K	Hold	22,700	–	–	﹤0.01%	1412
2015 Q1	$104K	Hold	22,700	–	–	﹤0.01%	1768
2014 Q4	$69K	Hold	22,700	–	–	﹤0.01%	1963
2014 Q3	$63K	Hold	22,700	–	–	﹤0.01%	1944
2014 Q2	$92K	Buy	+22,700	New	+$96.4K	﹤0.01%	1653

Other funds holding SGYP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

OCM

Opti Capital Management New York $1.64B AUM 0% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Canada Life's SGYP Position: Q4 2018 in Review

Canada Life sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 22,700 shares — an estimated $38K sold.

Canada Life first reported a position in SGYP in Q2 2014 and held it in 18 quarters. The position peaked at $188K in Q2 2015. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

Canada Life reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
Canada Life sold 22,700 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $38K.
Canada Life first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2014 and held it in 18 quarters.
Canada Life's Synergy Pharmaceuticals, Inc Common Stock position peaked at $188K in Q2 2015.
89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on Canada Life's 13F filing for Q4 2018, filed 12 Feb 2019.